The global Diabetes Supplements market gathered revenue around USD 10.9 billion in 2021 and market is set to grow USD 15.1 billion by the end of 2030 and is estimated to expand at a modest CAGR of 6.2% during the prediction period 2022 to 2030.
Growth Factors:
Diabetes, also known diabetes mellitus, is a metabolic disease resulting in high blood sugar. The hormone known as insulin is responsible for the movement of sugar from the blood into the cells, which is stored and used for providing energy to the body.
In case of diabetes, the body is either unable to produce enough insulin or cannot effectively utilize insulin produced. The two primary types of diabetes are type 1 diabetes and type 2 diabetes. In case of type 1 diabetes, the immune system attacks and destroys insulin producing cells in the pancreas, while in type 2 diabetes patients the body becomes resistant to insulin.
Dietary supplements are ingredients intended to enhance the diet of a person and contain vitamins, minerals, herbs, amino acids, metabolites, and other substances. These supplements are used to lower blood glucose, improve cholesterol, lower blood pressure, neuropathy, insulin resistance, and other complications in diabetic patients.
Report Scope of the Diabetes Supplements Market
|
Report Coverage |
Details |
|
Market Size |
US$ 15.1 Billion by 2030 |
|
Growth Rate |
CAGR of 6.2% from 2022 to 2030 |
|
Largest Market |
North America |
|
Fastest Growing Market |
Asia Pacific |
|
Base Year |
2021 |
|
Forecast Period |
2022 to 2030 |
|
Segments Covered |
Disease Type, Dosage Form, Distribution Channel, Type and Region, |
|
Companies Mentioned |
Abbott (Abbott Healthcare Pvt. Ltd.), Aksuvital Natural Products Co., Arkopharma, Bionova, Caelus Health, CuraLife Global, Glucose Health, Inc., Hexagon Nutrition Pvt. Ltd., La Grande P Ltd. (La Nutraceuticals), Lysulin, Inc., Nature's Sunshine Products, Inc., Nestlé Health Science, Nutricia |
Diabetes Supplements Market: Overview
Increase in Burden of Diabetes Globally
The prevalence of diabetes is rising across the globe. Diabetes is associated with lower quality of life and shorter life expectancy (eight years). Increase in sedentary lifestyle, aging, smoking, and excessive cholesterol levels is expected to boost the prevalence of diabetes, thereby propelling the demand for diabetes supplements.
According to a research conducted by the World Health Organization (WHO), in 2019, diabetes was the 9th major cause of death, with a projected 1.5 million deaths caused by diabetes. Diabetes is projected to be associated with around 11.3% deaths globally from all causes in people aged between 20 and 79 years. Owing to the above mentioned factors, the number of diabetes treatments has increased across the globe.
According to data published by Novo Nordisk, a Denmark-based multinational pharmaceutical company, around 183 million diabetic patients were treated in 2018, and is expected to increased steadily by 2025.
Vitamins to Lead Diabetes Supplements Market
In terms of type, the global diabetes supplements market has been classified into vitamins, minerals, proteins, antioxidant & fatty acids, dietary fibers, and others. The vitamins segment is anticipated to dominate the global market during the forecast period due to the launch of scientifically formulated vitamin supplements by prominent players and increase in awareness about vitamin-based diabetes supplements among patients.
Type 2 Segment to Dominate Global Diabetes Supplements Market
Based on disease type, the global diabetes supplements market has been divided into type 1 and type 2. Type 2 diabetes is the most consulted form of diabetes. According to various studies, prevalence of type 2 diabetes varies from 90% to 95% across the globe. Surge in geriatric population is expected to increase the incidence of type 2 diabetes across the globe, which is likely to drive the type 2 diabetes segment from 2022 to 2030.
Preference for Tablet Form of Supplements
In terms of dosage form, the global diabetes supplements market has been categorized into tablets, solution, powder, and others. Diabetic tablets can work to control diabetes. All the ingredients used are safe and completely natural. The herbal properties help improve insulin sensitivity and stimulate insulin release in diabetic patients.
Retail Pharmacies to be Key Distribution Channel
Based on distribution channel, the global diabetes supplements market has been divided into hospital pharmacies, retail pharmacies, and online pharmacies. Wide availability of diabetes supplements and expansion of retail pharmacies base are anticipated to propel the retail pharmacies segment over the next few years. According to various independent surveys, retail pharmacies are primary consultation centers in several low- and middle-income countries in Asia Pacific and Latin America. Moreover, several international, corporate, and retail pharmacies are expanding their base in these region; for instance, Watson in the Philippines and Boots in South Korea and China.
North America to Lead Diabetes Supplements Market
The global diabetes supplements market has been segmented into North America, Europe, Latin America, Asia Pacific, and Middle East & Africa. Increase in geriatric population and high prevalence of chronic diseases in the region are projected to drive the diabetes supplements market in North America during the forecast period. Moreover, rise in healthcare expenditure by public and private sectors is expected to fuel the growth of the market in the region.
Some of the prominent players in the Diabetes Supplements Market include:
Segments Covered in the Report
This research report offers market revenue, sales volume, production assessment and prognoses by classifying it on the basis of various aspects. Further, this research study investigates market size, production, consumption and its development trends at global, regional, and country level for the period of 2017 to 2030 and covers subsequent region in its scope:
By Geography
North America
Europe
Asia Pacific
Latin America
Middle East & Africa (MEA)
Key Points Covered in Diabetes Supplements Market Study:
1. Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary: Global Diabetes Supplements Market
4. Market Overview
4.1. Introduction
4.1.1. Market Introduction
4.1.2. Industry Evolution / Developments
4.2. Overview
4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunities
4.4. Global Diabetes Supplements Market Analysis and Forecast, 2017–2030
5. Key Insights
5.1. COVID-19 Pandemics Impact on Industry (value chain and short / mid / long term impact)
5.2. Key Industry Events (products launch, approval, merger & acquisition, etc.)
5.3. Epidemiology of Diabetes, by Region/Country
6. Global Diabetes Supplements Market Analysis and Forecast, by Type
6.1. Introduction & Definition
6.2. Key Findings / Developments
6.3. Market Value Forecast, by Type, 2017–2030
6.3.1. Vitamins
6.3.2. Minerals
6.3.3. Proteins
6.3.4. Antioxidant & Fatty Acids
6.3.5. Dietary Fibers
6.3.6. Others
6.4. Market Attractiveness Analysis, by Type
7. Global Diabetes Supplements Market Analysis and Forecast, by Disease Type
7.1. Introduction & Definition
7.2. Key Findings / Developments
7.3. Market Value Forecast, by Disease Type, 2017–2030
7.3.1. Type 1
7.3.2. Type 2
7.4. Market Attractiveness Analysis, by Disease Type
8. Global Diabetes Supplements Market Analysis and Forecast, by Dosage Form
8.1. Introduction & Definition
8.2. Key Findings / Developments
8.3. Market Value Forecast, by Dosage Form, 2017–2030
8.3.1. Tablets
8.3.2. Solution
8.3.3. Powder
8.3.4. Others
8.4. Market Attractiveness Analysis, by Dosage Form
9. Global Diabetes Supplements Market Analysis and Forecast, by Distribution Channel
9.1. Introduction & Definition
9.2. Key Findings / Developments
9.3. Market Value Forecast, by Distribution Channel, 2017–2030
9.3.1. Hospital Pharmacies
9.3.2. Retail Pharmacies
9.3.3. Online Pharmacies
9.4. Market Attractiveness Analysis, by Distribution Channel
10. Global Diabetes Supplements Market Analysis and Forecast, by Region
10.1. Key Findings
10.2. Market Value Forecast, by Region
10.2.1. North America
10.2.2. Europe
10.2.3. Asia Pacific
10.2.4. Latin America
10.2.5. Middle East & Africa
10.3. Market Attractiveness Analysis, by Region
11. North America Diabetes Supplements Market Analysis and Forecast
11.1. Introduction
11.1.1. Key Findings
11.2. Market Value Forecast, by Type, 2017–2030
11.2.1. Vitamins
11.2.2. Minerals
11.2.3. Proteins
11.2.4. Antioxidant & Fatty Acids
11.2.5. Dietary Fibers
11.2.6. Others
11.3. Market Value Forecast, by Disease Type, 2017–2030
11.3.1. Type 1
11.3.2. Type 2
11.4. Market Value Forecast, by Dosage Form, 2017–2030
11.4.1. Tablets
11.4.2. Solution
11.4.3. Powder
11.4.4. Others
11.5. Market Value Forecast, by Distribution Channel, 2017–2030
11.5.1. Hospital Pharmacies
11.5.2. Retail Pharmacies
11.5.3. Online Pharmacies
11.6. Market Value Forecast, by Country, 2017–2030
11.6.1. U.S.
11.6.2. Canada
11.7. Market Attractiveness Analysis
11.7.1. By Type
11.7.2. By Disease Type
11.7.3. By Dosage Form
11.7.4. By Distribution Channel
11.7.5. By Country
12. Europe Diabetes Supplements Market Analysis and Forecast
12.1. Introduction
12.1.1. Key Findings
12.2. Market Value Forecast, by Type, 2017–2030
12.2.1. Vitamins
12.2.2. Minerals
12.2.3. Proteins
12.2.4. Antioxidant & Fatty Acids
12.2.5. Dietary Fibers
12.2.6. Others
12.3. Market Value Forecast, by Disease Type, 2017–2030
12.3.1. Type 1
12.3.2. Type 2
12.4. Market Value Forecast, by Dosage Form, 2017–2030
12.4.1. Tablets
12.4.2. Solution
12.4.3. Powder
12.4.4. Others
12.5. Market Value Forecast, by Distribution Channel, 2017–2030
12.5.1. Hospital Pharmacies
12.5.2. Retail Pharmacies
12.5.3. Online Pharmacies
12.6. Market Value Forecast, by Country/Sub-region, 2017–2030
12.6.1. Germany
12.6.2. U.K.
12.6.3. France
12.6.4. Spain
12.6.5. Italy
12.6.6. Rest of Europe
12.7. Market Attractiveness Analysis
12.7.1. By Type
12.7.2. By Disease Type
12.7.3. By Dosage Form
12.7.4. By Distribution Channel
12.7.5. By Country/Sub-region
13. Asia Pacific Diabetes Supplements Market Analysis and Forecast
13.1. Introduction
13.1.1. Key Findings
13.2. Market Value Forecast, by Type, 2017–2030
13.2.1. Vitamins
13.2.2. Minerals
13.2.3. Proteins
13.2.4. Antioxidant & Fatty Acids
13.2.5. Dietary Fibers
13.2.6. Others
13.3. Market Value Forecast, by Disease Type, 2017–2030
13.3.1. Type 1
13.3.2. Type 2
13.4. Market Value Forecast, by Dosage Form, 2017–2030
13.4.1. Tablets
13.4.2. Solution
13.4.3. Powder
13.4.4. Others
13.5. Market Value Forecast, by Distribution Channel, 2017–2030
13.5.1. Hospital Pharmacies
13.5.2. Retail Pharmacies
13.5.3. Online Pharmacies
13.6. Market Value Forecast, by Country/Sub-region, 2017–2030
13.6.1. China
13.6.2. Japan
13.6.3. India
13.6.4. Australia & New Zealand
13.6.5. Rest of Asia Pacific
13.7. Market Attractiveness Analysis
13.7.1. By Type
13.7.2. By Disease Type
13.7.3. By Dosage Form
13.7.4. By Distribution Channel
13.7.5. By Country/Sub-region
14. Latin America Diabetes Supplements Market Analysis and Forecast
14.1. Introduction
14.1.1. Key Findings
14.2. Market Value Forecast, by Type, 2017–2030
14.2.1. Vitamins
14.2.2. Minerals
14.2.3. Proteins
14.2.4. Antioxidant & Fatty Acids
14.2.5. Dietary Fibers
14.2.6. Others
14.3. Market Value Forecast, by Disease Type, 2017–2030
14.3.1. Type 1
14.3.2. Type 2
14.4. Market Value Forecast, by Dosage Form, 2017–2030
14.4.1. Tablets
14.4.2. Solution
14.4.3. Powder
14.4.4. Others
14.5. Market Value Forecast, by Distribution Channel, 2017–2030
14.5.1. Hospital Pharmacies
14.5.2. Retail Pharmacies
14.5.3. Online Pharmacies
14.6. Market Value Forecast, by Country/Sub-region, 2017–2030
14.6.1. Brazil
14.6.2. Mexico
14.6.3. Rest of Latin America
14.7. Market Attractiveness Analysis
14.7.1. By Type
14.7.2. By Disease Type
14.7.3. By Dosage Form
14.7.4. By Distribution Channel
14.7.5. By Country/Sub-region
15. Middle East & Africa Diabetes Supplements Market Analysis and Forecast
15.1. Introduction
15.1.1. Key Findings
15.2. Market Value Forecast, by Type, 2017–2030
15.2.1. Vitamins
15.2.2. Minerals
15.2.3. Proteins
15.2.4. Antioxidant & Fatty Acids
15.2.5. Dietary Fibers
15.2.6. Others
15.3. Market Value Forecast, by Disease Type, 2017–2030
15.3.1. Type 1
15.3.2. Type 2
15.4. Market Value Forecast, by Dosage Form, 2017–2030
15.4.1. Tablets
15.4.2. Solution
15.4.3. Powder
15.4.4. Others
15.5. Market Value Forecast, by Distribution Channel, 2017–2030
15.5.1. Hospital Pharmacies
15.5.2. Retail Pharmacies
15.5.3. Online Pharmacies
15.6. Market Value Forecast, by Country/Sub-region, 2017–2030
15.6.1. GCC Countries
15.6.2. South Africa
15.6.3. Rest of Middle East & Africa
15.7. Market Attractiveness Analysis
15.7.1. By Type
15.7.2. By Disease Type
15.7.3. By Dosage Form
15.7.4. By Distribution Channel
15.7.5. By Country/Sub-region
16. Competition Landscape
16.1. Market Player – Competition Matrix (by Tier and Size of companies)
16.2. Market Share Analysis/Ranking by Company (2020)
16.3. Company Profiles
16.3.1. Abbott (Abbott Healthcare Pvt. Ltd.)
16.3.1.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.1.2. Company Financials
16.3.1.3. Growth Strategies
16.3.1.4. SWOT Analysis
16.3.2. Aksuvital Natural Products Co.
16.3.2.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.2.2. Company Financials
16.3.2.3. Growth Strategies
16.3.2.4. SWOT Analysis
16.3.3. Arkopharma
16.3.3.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.3.2. Company Financials
16.3.3.3. Growth Strategies
16.3.3.4. SWOT Analysis
16.3.4. Bionova
16.3.4.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.4.2. Company Financials
16.3.4.3. Growth Strategies
16.3.4.4. SWOT Analysis
16.3.5. Caelus Health
16.3.5.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.5.2. Company Financials
16.3.5.3. Growth Strategies
16.3.5.4. SWOT Analysis
16.3.6. CuraLife Commerce SIA
16.3.6.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.6.2. Company Financials
16.3.6.3. Growth Strategies
16.3.6.4. SWOT Analysis
16.3.7. Glucose Health, Inc.
16.3.7.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.7.2. Company Financials
16.3.7.3. Growth Strategies
16.3.7.4. SWOT Analysis
16.3.8. Hexagon Nutrition Pvt. Ltd.
16.3.8.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.8.2. Company Financials
16.3.8.3. Growth Strategies
16.3.8.4. SWOT Analysis
16.3.9. La Grande P Ltd. (La Nutraceuticals)
16.3.9.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.9.2. Company Financials
16.3.9.3. Growth Strategies
16.3.9.4. SWOT Analysis
16.3.10. Lysulin, Inc.
16.3.10.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.10.2. Company Financials
16.3.10.3. Growth Strategies
16.3.10.4. SWOT Analysis
16.3.11. Nature's Sunshine Products, Inc.
16.3.11.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.11.2. Company Financials
16.3.11.3. Growth Strategies
16.3.11.4. SWOT Analysis
16.3.12. Nestlé Health Science
16.3.12.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.12.2. Company Financials
16.3.12.3. Growth Strategies
16.3.12.4. SWOT Analysis
16.3.13. Nutricia
16.3.13.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.13.2. Company Financials
16.3.13.3. Growth Strategies
16.3.13.4. SWOT Analysis
16.3.14. Olive Healthcare
16.3.14.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.14.2. Company Financials
16.3.14.3. Growth Strategies
16.3.14.4. SWOT Analysis
16.3.15. Other Prominent Players
16.3.15.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.15.2. Company Financials
16.3.15.3. Growth Strategies
16.3.15.4. SWOT Analysis
Cross-segment Market Size and Analysis for
Mentioned Segments
Additional Company Profiles (Upto 5 With No Cost)
Additional Countries (Apart From Mentioned Countries)
Country/Region-specific Report
Go To Market Strategy
Region Specific Market DynamicsRegion Level Market Share Import Export AnalysisProduction AnalysisOthers